Therapeutic antibodies targeting app-c99

The present invention relates to an isolated and/or purified antibody, antibody fragment or derivative thereof able to block the gamma-secretase-dependent processing of the amyloid precursor protein (APP) and to pharmaceutical compositions containing said antibody/ies.


Year:
2012
Other identifiers:
TTO: 6.1053
EPO Family ID: 45768263
Patent number(s):
Laboratories:




 Record created 2015-09-22, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)